Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs). The FDA has ...
In a controversial decision that hands a victory to Purdue Pharma, the US Food and Drug Administration has banned copycat versions of the maker’s painkiller OxyContin (oxycodone). The opiate drug has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results